The AHA/ACC/HFSA 2022 Heart Failure Guidelines: Changing the Focus to Heart Failure Prevention
The prevalence of heart failure (HF) in the United States (U.S.) is estimated at over 6 million adults, with the incidence continuing to increase. A large proportion of the U.S. population is also at risk of HF due to the high prevalence of established HF risk factors, such as hypertension, diabetes...
Main Authors: | Arielle Abovich, Daniel S. Matasic, Rhanderson Cardoso, Chiadi E. Ndumele, Roger S. Blumenthal, Ron Blankstein, Martha Gulati |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-09-01
|
Series: | American Journal of Preventive Cardiology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666667723000685 |
Similar Items
-
ACC/AHA/HFSA 2022 and ESC 2021 guidelines on heart failure comparison
by: Amir Hossein Behnoush, et al.
Published: (2023-06-01) -
Summary and Comparison of the 2022 ACC/AHA/HFSA and 2021 ESC Heart Failure Guidelines
by: Sarah Badger, et al.
Published: (2023-08-01) -
Interpretation of the Essential Updates in 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
by: Yifang GUO
Published: (2022-06-01) -
2016 ESC and ACC/AHA/HFSA heart failure guideline updates: Changes, similarities, differences, and unresolved isssues
by: İbrahim Sarı, et al.
Published: (2016-12-01) -
USE OF SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS BY CARDIOLOGISTS SINCE THE RELEASE OF 2022 AHA/ACC/HFSA GUIDELINES FOR THE MANAGEMENT OF HEART FAILURE
by: Gowtham R. Grandhi, MD MPH, et al.
Published: (2023-09-01)